Akil Merchant

16PUBLICATIONS
133CO-AUTHORS
Tumour immunologyMedical infection agents (incl. prions)Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jan 30, 2026
Multidimensional Characterization of Tumor-Immune Architecture Reveals Clinically Relevant Classic Hodgkin Lymphoma Subtypes.

Tomohiro Aoki, Gerben Duns, Shinya Rai

|Dec 05, 2025
Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosis.

Xue Kong, Zijun Y Xu-Monette, Zhenming Xu

|Nov 05, 2025
Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma.

Sunandini Sharma, Roshia Ali, Alyssa Bouska

|Sep 09, 2025
Tumor microenvironment differences between diagnostic and relapsed classic Hodgkin lymphoma revealed by scRNA-seq.

Yifan Yin, Shinya Rai, Aixiang Jiang

|May 19, 2025
Smoothened Inhibitor, PF-04449913 Inhibits the Development of Myelofibrosis in a JAK2V617F Transgenic Mouse Model by Reducing TGF-β and MAPK Signaling Pathways.

Akil Merchant, Parvesh Chaudhry, Mohan Singh

|Apr 25, 2024
Sequencing of Anti-CD19 Therapies in the Management of Diffuse Large B-Cell Lymphoma.

Joseph Lownik, Jonathan Boiarsky, Ruemu Birhiray

Pageof 3

Frequent Collaborators

7 joint publications

Alexander Xu

4 joint publications

Tomohiro Aoki

3 joint publications

Christian Steidl

3 joint publications

Kerry J Savage